Search Results 41-50 of 15902 for Residual

  1. Spasticity After Spinal Cord Injury - Clinical Trials

    About this study. A growing body of research demonstrates a correlation between residual corticospinal connectivity and severity of spasticity following SCI ...

  2. Overactive bladder - Diagnosis and treatment - Mayo Clinic

    To measure residual urine after you void, your health professional may want an ultrasound scan of your bladder. The ultrasound scan translates sound waves into ...

  3. CLIP-IT Post Market Study: Exclusion of the Left Atrial Appendage With Penditure™ - Mayo Clinic

    ... residual communication (≤ 3 mm residual jet velocity communication) between the left atrium (LA) and the LAA. For those successfully placed devices ...

  4. A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy Duration - Mayo Clinic

    A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy ...

  5. Cancer survivors: Late effects of cancer treatment - Mayo Clinic

    These include chemotherapy, hormone therapy, radiation, surgery, targeted therapy and immunotherapy. As newer cancer treatments become available, these might be ...

  6. Mayo Clinic pilot study pinpoints resectable high-grade serous ovarian cancer

    ... residual disease" of her gynecologic oncology team treating patients with HGSOC. This obsession developed because any postsurgical residual disease beyond 1 ...

  7. Urinary incontinence - Diagnosis and treatment - Mayo Clinic

    Postvoid residual measurement. You're asked to urinate (void) into a container that measures urine output. Then your doctor checks the amount of leftover ...

  8. Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial - Mayo Clinic

    Giving lenalidomide and ixazomib together may work better than giving lenalidomide alone in treating patients with evidence of residual multiple myeloma after a ...

  9. centers-of-excellence

    Mutter, M.D., investigates ways to enhance the efficacy of radiotherapy in patients with resistant breast cancer (residual ... Roberta H. Adams, M.D. - Mayo ...

  10. Study Of Sacituzumab Govitecan-hziy And Pembrolizumab Versus Treatment Of Physician's Choice In Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery And Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) - Mayo Clinic

    Study Of Sacituzumab Govitecan-hziy And Pembrolizumab Versus Treatment Of Physician's Choice In Patients With Triple Negative Breast Cancer Who Have Residual ...